Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
South African Press Association - September 17, 2008
University of KwaZulu-Natal Professor Salim Karim, who is also a director of the Centre for the Aids Programme Research in South Africa, made the announcement at a media briefing in Durban on Wednesday.
He said a trial that started in June 2005 showed that mortality could be reduced among co-infected TB-HIV patients.
During the trial, the progress of TB-HIV co-infected patients who received ART together with their TB treatment was compared to that of patients assigned to receive ART after TB treatment.
"The study shows that integrating TB and HIV treatment and care saves lives ...," said Karim.
"The results provide compelling evidence to support the World Health Organisation's call for greater collaboration between TB and HIV treatment services ..."
Coordinator of the United States President's Emergency Plan for Aids Relief (Pepfar) Mark Dybul said the scaling up of collaborative TB/HIV activities was a priority for the organisation
"We remain committed to increasing screening for both HIV and TB, which will allow greater numbers of patients to benefit from these study results."
In South Africa, it is estimated that about 70% of all TB patients are infected with HIV.
080917
SA080905
Copyright © 2008 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .